Related Experiment Videos
Prolactin activates interferon regulatory factor-1 expression in normal lympho-hemopoietic cells
Z Dogusan1, M L Book, P Verdood
1Department of Pharmacology, Medical School, Free University of Brussels (VUB), Laarbeeklaan, 103, B-1090 Brussels, Belgium.
European Cytokine Network
|October 7, 2000
Summary
Prolactin (PRL) acts as a growth factor for immune cells. This study shows PRL activates key signaling pathways in rat bone marrow and spleen cells, influencing immune responses.
Area of Science:
- Immunology
- Endocrinology
- Molecular Biology
Background:
- Prolactin (PRL) is suggested to be a lympho-hemopoietic growth and differentiation factor.
- Understanding the molecular mechanisms of PRL's action on immune cells is crucial.
Purpose of the Study:
- To investigate the expression of prolactin receptors (PRL-R) in rat bone marrow and spleen.
- To elucidate the signaling pathways activated by PRL in these immune cells.
- To determine the effect of PRL on interferon regulatory factor-1 (IRF-1) gene expression.
Main Methods:
- Western blotting to detect PRL-R expression.
- Analysis of Janus tyrosine kinase (JAK)-2 phosphorylation.
- Electromobility shift assay to study signal transducer and activator of transcription (Stat) 5b binding.
- Reverse transcription-polymerase chain reaction (RT-PCR) to assess IRF-1 gene expression.
Main Results:
- PRL-receptors (PRL-R) were detected in normal rat bone marrow and spleen cells.
- PRL stimulation led to JAK-2 phosphorylation in these cells.
- PRL induced Stat5b binding to the IRF-1 gamma activation sequence (GAS).
- Physiological concentrations of PRL stimulated IRF-1 gene expression.
Conclusions:
- Prolactin signaling pathways involving JAK-2 and Stat5b are active in rat immune cells.
- PRL influences the expression of IRF-1, a key immune-related gene.
- These findings support the role of prolactin in regulating immune responses.